期刊文献+

依普黄酮固体分散体的制备和溶出特性(英文) 被引量:2

Preparation and dissolution property of ipriflavone solid dispersion
原文传递
导出
摘要 目的:制备和鉴定依普黄酮固体分散体,测定它的体外溶出度。方法:用溶剂法制备依普黄酮固体分散体,用DSC,X衍射和红外光谱鉴定固体分散体,浆法测定它的溶出度。结果:由依普黄酮和聚维酮(1:8)组成的固体分散体,其体外溶出度是依普黄酮的6.15倍,DSC曲线,X衍射图谱和红外光谱均产生了明显变化。结论:依普黄酮被制成固体分散体能明显增加依普黄酮的体外溶出度。 AIM: To prepare and identify ipriflavone (IP) solid dispersion, and determine its dissolution property. METHODS: The solvent method was used for preparation and differential scanning calorimetry (DSC), X-ray diffraction and infrared spectrophoto-metry for identification of IP solid dispersion. The dissolution of the dispersion was determined with paddle method. RESULTS: The dissolution of IP solid dispersion consisting of IP and povidone-k30 (PVP) (1 :8) in artificial gastric juice is 6.15 times as high as that of IP alone. The DSC curves, X-ray diffraction patterns and infrared spectrophotometries of IP have been changed obviously by the dispersion. CONCLUSION: The dissolution of IP is increased by solid dispersion method.
出处 《中国药理学报》 CSCD 1999年第10期957-960,共4页 Acta Pharmacologica Sinica
关键词 依普黄酮 异黄酮 制剂 聚维酮 制备 溶出特性 ipriflavones isoflavones pharmaceutical preparations povidone polyethylene glycols
  • 相关文献

参考文献3

  • 1Choi Y K,Osteoporosis,1997年,7卷,Suppl期,S174页
  • 2Kai T,Chem Pharm Bull,1996年,44卷,3568页
  • 3Yu A B C,Applied Biopharmaceutics and Pharmacokinetics,1996年

同被引文献29

  • 1郑俊民,杨丽,何有清,李桂芝.应用DSC测定硝苯地平的纯度[J].沈阳药科大学学报,1995,12(1):10-13. 被引量:5
  • 2.复方丹参滴丸[A]..为欧共体药审委传统立法小组推荐中药优秀产品资料汇编[M].北京:中国医药科技出版社,2002.27.
  • 3Sekiguchi K, Obi N. Studies on absorption of eutectic mixture Ⅰ .A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man[J].Chem Pharm Bull,1961,9(11): 866-869.
  • 4USP X X ,NF X V .Rockville United States Pharmacopoeia Convention[M].1980.368.
  • 5Martindale. The extra pharmacopoeia[M].29th. London: The pharmaceutics press, 1989.1101.
  • 6Serajuddin AT, Sheen PC, AugustineMA. Improved dissolution of a poorly water soluble drug from solid dispersions in PEG:polysorbate 80[J].J Pharm Sci, 1990,79(5): 463.
  • 7Miralles MJ, Mcginty JW, Martin A. Combined water soluble carriers for coprecipitates of toibutamide[J].J Pharm Sci,1982,71(3): 302.
  • 8Hasegawa A, Nakagawa H, Sugimoto I. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form[J]. Chem Pharm Bull, 1985, 33(4):1615.
  • 9Ohnishi N, Yokoyama T, Umeds T, et al. Preparation of sustained released granules of nifedipine using a solid dispersion system and pharmacokinetic study after oral administration to rabbits[J]. Yakugaku Zasshi, 1986,106(12):1131.
  • 10Oth MP, Moes AJ. Sustained released solid dispersions of indomethacin with Eudragit RS and RL[J]. Int J Pharm, 1989, 55:157.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部